Litcius/Paper detail

Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial

Tristan Clark, Kate Beard, Nathan J. Brendish, Ahalya Malachira, Samuel Mills, Cathleen Chan, Stephen Poole, Sean Ewings, Nick Cortes, Esther Nyimbili, Laura Presland

2020The Lancet Respiratory Medicine50 citationsDOIOpen Access PDF

Topics & Concepts

MedicineNeuraminidase inhibitorClinical endpointClinical trialRandomized controlled trialEmergency medicineOseltamivirIsolation (microbiology)PediatricsIntensive care medicineInternal medicineCoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)BiologyMicrobiologyInfluenza Virus Research StudiesRespiratory viral infections researchPneumonia and Respiratory Infections
Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial | Litcius